InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Sunday, 11/23/2014 4:05:24 PM

Sunday, November 23, 2014 4:05:24 PM

Post# of 80868
$200 million is a fair price for Musclepharm in an acquisition as of today.

There is currently too much of a management risk to believe in a higher value of Musclepharm.

The company's management doesn't act like the company is under SEC investigation, got limited cash or is a public company.
The management makes an expensive and dilutive bet on Tiger Woods while issuing way too many shares to employees....
Also, the company's pricing and branding strategy for Arnold Iron across different channels is completely broken.